BAGSVAERD, DENMARK--(Marketwire - April 02, 2012) - In continuation of the company's
announcements dated 2 November 2011 and 2
February 2012 concerning planned share repurchase programmes, and pursuant
Section 204.25 of the New York Stock Exchange Listed Company Manual, this
report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on
March 2012 owned 27,329,627 of its own B shares of DKK 1, corresponding to
total nominal value of DKK 27,329,627 or 4.71% of the total share capital.
Company Anouncement no 21 2012:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE